Menu
GeneBe

PCDHA10

protocadherin alpha 10, the group of Clustered protocadherins

Basic information

Region (hg38): 5:140855882-141012347

Previous symbols: [ "CNRS8" ]

Links

ENSG00000250120NCBI:56139OMIM:606316HGNC:8664Uniprot:Q9Y5I2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PCDHA10 gene.

  • Inborn genetic diseases (253 variants)
  • not provided (37 variants)
  • not specified (1 variants)
  • Thrombocytosis (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PCDHA10 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
10
clinvar
10
missense
39
clinvar
4
clinvar
43
nonsense
1
clinvar
1
start loss
1
clinvar
1
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
199
clinvar
36
clinvar
1
clinvar
236
Total 0 0 239 52 1

Variants in PCDHA10

This is a list of pathogenic ClinVar variants found in the PCDHA10 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-140855984-ATGTCAGATCGTATGTGCGTTCTAGACCGCTGATTCGTCGATTTGTAAAACAAGAGAAGGATAAGATGGTTTCCAGATGTAGCTGCCTGGGGGTCCAGTGTCTGCTGCTCTCGCTTCTTCTCCTCGCAGCCTGGGAGGTGGGGAGCGGCCAGCTCCACTACTCAGTCTACGAGGAGGCCAGACACGGCACCTTCGTGGGCCGCATCGCGCAGGACCTGGGGCTGGAGCTGGCGGAGCTGGTGCAGCGCCTGTTCCGGGTGGCGTCCAAAAGACACGGGGACCTTCTGGAGGTAAATCTGCAGAATGGCATTTTGTTTGTGAATTCTCGGATTGACCGCGAGGAGCTGTGCGGGCGGAGCGTGGAGTGCAGCATCCACCTGGAGGTGATCGTGGACAGGCCGCTGCAGGTTTTCCATGTGGACGTGGAAGTGAAGGACATTAACGACAACCCGCCCAGGTTCTCCGTAACAGAACAAAAGCTCTCAATACCTGAATCCAGACTGCTTGACTCTCGATTTCCACTAGAAGGCGCATCTGATGCGGATGTTGGAGAGAACGCATTGCTTACTTACAAACTCAGTCCAAATGAGTATTTTGTTCTTGATATTATAAACAAAAAAGACAAAGACAAATTCCCAGTGCTTGTTCTGCGGAAGCTGCTGGATCGTGAAGAAAATCCTCAGCTAAAGTTGTTGTTGACAGCAACTGATGGAGGCAAACCTGAATTTACCGGATCTGTTTCTCTGCTGATCCTGGTGTTAGATGCCAATGATAACGCCCCTATCTTTGACAGACCGGTTTATGAAGTTAAGATGTATGAAAATCAAGTGAACCAAACATTAGTAATACGGCTCAACGCTTCTGATTCGGATGAAGGAATAAACAAGGAAATGATGTATTCATTTAGCTCTTTGGTCCCACCCACGATAAGAAGGAAATTTTGGATAAACGAAAGGACGGGAGAAATAAAAGTAAATGATGCTATTGACTTTGAGGACAGTAACACTTATGAAATTCATGTAGATGTTACAGATAAGGGAAACCCACCTATGGTTGGTCACTGCACGGTCCTAGTGGAACTACTGGATGAAAATGATAATTCACCTGAGGTGATTGTCACTTCTCTGTCTCTCCCAGTGAAAGAAGATGCTCAAGTGGGCACCGTCATTGCCCTAATCAGCGTTTCTGACCATGATTCAGGAGCCAACGGACAGGTCACCTGCTCTCTGACGCCTCACGTTCCGTTCAAGCTGGTGTCCACCTACAAGAATTACTACTCATTGGTGCTGGACAGCGCTCTGGACCGCGAGAGGGTGTCGGCCTATGAGCTGGTGGTGACCGCGCGGGACGGGGGCTCGCCTCCGCTGTGGGCCACGGCCAGCGTGTCTGTGGAGGTGGCCGACGTGAACGACAACGCGCCTGCGTTCGCGCAGTCCGAGTACACGGTGTTCGTGAAGGAGAACAACCCGCCAGGCTGCCACATCTTCACGGTGTCTGCGTGGGACGCGGACGCGCAGGAGAACGCCCTGGTGTCCTACTCTCTGGTGGAGCGGCGGTTGGGCGAGCGCTCGCTGTCGAGCTACGTGTCGGTGCACGCGGAGAGCGGCAAGGTGTACGCGCTGCAGCCGCTGGACCACGAGGAGCTGGAGCTGCTACAGTTCCAGGTGAGCGCGCGCGATGGGGGCGTGCCGCCTCTGGGCAGCAACTTGACGCTGCAGGTGTTCGTGCTGGACGAGAACGACAACGCTCCCGCGCTGCTGGCGTCTCCCGCTGGCAGCGCGGGCGGTGCAGTCAGTGAGCTGGTGCTGCGGTCGGTGGTTGCGGGTCACGTGGTGGCTAAGGTGCGCGCAGTGGACGCTGACTCTGGATACAACGCGTGGCTGTCGTATGAATTGCAGTCGGCGGCGGTTGGTGCACGCATCCCGTTTCGCGTGGGGCTGTACACGGGCGAGATCAGTACGACGCGCGCTCTGGATGAGACTGACTCGCCACGCCAGCGCCTACTGGTGCTGGTGAAGGACCATGGCGAGCCGTCGCTGACGGCCACGGCCACTGTGCTTGTGTCGCTTGTGGAGGGCAGCCAGGCACCCAAGGCCTCGTCGCGGGCTTCAGTGGGCGTGGCGCCCGAGGTGGCCCTGGTGGATGTCAACGTGTACCTGATCATCGCCATCTGCGCGGTGTCCAGCTTGCTGGTGCTCACGCTGCTGCTGTACACTGCACTGAGGTGCTCGGCGGCGCCCACCGAGGGCGCATGTGGGCCGGTGAAGCCCACGCTGGTGTGCTCTAGCGCGGTGGGGAGCTGGTCTTACTCGCAGCAGAGGCGGCAGAGGGTGTGTTCTGGGGAGGGCCTGCCCAAGGCGGACCTCATGGCCTTCAGCCCCAGCCTTCCACCATGCCCAATGGTAGATGTGGACGGGGAAGATCAGTCTATTGGAGGGGACCACTCTAGGAAGGTGGGTTATTACGTTTTCATTTTCCTTTTGTGCTTTATGAATAATATTTTCTCTTACCGCATTTTCTCAAATATGTATCAGAATATTTCATTTTTGTCTACATTCCATTTATGCTTGAATATTTCTAGTGATACCTTTGTAATATAATTTATTCCAGGAGTTTTAAAATTTTTTTATCCTACCCAGTGTGTCAGCCTTTGAT-A Thrombocytosis Uncertain significance (Apr 16, 2019)975862
5-140856129-C-G not specified Uncertain significance (Jan 03, 2022)2268803
5-140856139-C-T not specified Uncertain significance (Aug 16, 2021)2245569
5-140856148-G-A not specified Uncertain significance (Jan 23, 2024)3209281
5-140856167-A-T not specified Uncertain significance (Aug 04, 2021)2367147
5-140856191-C-T not specified Uncertain significance (May 24, 2023)2551432
5-140856202-G-A not specified Uncertain significance (Jul 11, 2023)2589246
5-140856215-C-A not specified Uncertain significance (Jan 31, 2022)2335002
5-140856227-A-C Likely benign (Oct 01, 2023)2655777
5-140856259-G-T not specified Uncertain significance (Jul 26, 2023)2596846
5-140856269-T-C not specified Uncertain significance (Feb 07, 2023)2456261
5-140856320-G-T not specified Uncertain significance (Jan 20, 2023)2476948
5-140856323-A-G not specified Uncertain significance (Mar 11, 2022)2278107
5-140856338-G-T not specified Uncertain significance (Jan 23, 2024)3209300
5-140856417-G-C not specified Uncertain significance (Dec 02, 2022)2332074
5-140856428-A-G not specified Uncertain significance (May 24, 2023)2524484
5-140856533-G-T not specified Uncertain significance (Mar 23, 2022)2237644
5-140856537-G-T not specified Uncertain significance (Nov 30, 2022)2341756
5-140856558-A-C not specified Uncertain significance (Oct 10, 2023)3209301
5-140856558-A-T not specified Uncertain significance (Feb 27, 2023)2490092
5-140856564-T-G not specified Uncertain significance (Dec 01, 2022)2399867
5-140856599-A-G not specified Uncertain significance (Nov 08, 2022)2324493
5-140856698-G-A not specified Uncertain significance (Feb 17, 2024)3209302
5-140856749-C-T not specified Uncertain significance (Jun 23, 2021)2388587
5-140856809-A-G not specified Uncertain significance (Jan 23, 2024)3209303

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PCDHA10protein_codingprotein_codingENST00000307360 4156335
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.09e-140.0870125002396931257340.00292
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.7566475951.090.00004166079
Missense in Polyphen213192.841.10462161
Synonymous-0.3142972901.020.00002452060
Loss of Function0.7252327.10.8500.00000132325

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.007680.00738
Ashkenazi Jewish0.005870.00517
East Asian0.001690.00163
Finnish0.01010.00961
European (Non-Finnish)0.001920.00177
Middle Eastern0.001690.00163
South Asian0.003090.00294
Other0.002480.00212

dbNSFP

Source: dbNSFP

Function
FUNCTION: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain.;

Recessive Scores

pRec
0.108

Intolerance Scores

loftool
0.925
rvis_EVS
1.61
rvis_percentile_EVS
95.93

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.172
ghis
0.402

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerHighMediumHigh

Mouse Genome Informatics

Gene name
Pcdha9
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Gene ontology

Biological process
cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;nervous system development
Cellular component
extracellular region;integral component of plasma membrane
Molecular function
calcium ion binding